Recently, the official website of the China Chamber of Commerce for Import and Export of Pharmaceutical and Healthcare Products, updated the list of medical supplies manufacturers that have obtained foreign standard certification or registration. TargetingOne has entered the "White List" of the Ministry of Commerce for the export of epidemic prevention materials with SARS-COV-2 Antigen Test, SARS-COV-2 and Influenza A/B Antigen Combo Test
SARS-COV-2 antigen test series kits
Excellent performance: High sensitivity, high specificity, good reproducibility. Negative-positive compliance rate 100%.
Fast detection result: short reading time, only 10 minutes [extended reading time of up to 20 minutes], deep color display.
Convenient: Swab sampling does not need to go deep inside the nasal cavity, reducing patient pain.
Easy to store: Stored at room temperature with a 24-month warranty.
Limit of Detection: Minimum 100 TCID50/mL; the minimum detection limit of the reference product can be detected up to S7.
Multiple Sizes: 1 test, 5 tests and 25 tests.
Antigen rapid test kits, with shorter detection time, lower cost and more convenient self-test, play an important role in the auxiliary screening of suspected patients, screening of high-risk groups and self-test, and can be used as an auxiliary means of screening for new crown infections.
In addition to the products that have already entered the "white list" of the Ministry of Commerce for export of epidemic prevention materials, there are now 6 products, including: NSARS-COV-2 Antigen Test(Latex immunochromatography method), SARS-COV-2 and Influenza A/B Antigen Combo Test(Latex immunochromatography method), Novel Coronavirus(2019-nCov) Nucleic Acid Detection Kit(Digital PCR Method), Nucleic acid extraction reagent (magnetic bead method), SARS-COV-2 Nucleic Acid Detection Kits(Fluorescent PCR Method), SARS-COV-2 and Influenza A/B Nucleic Acid Detection Kits(Fluorescent PCR Method)
Now, the new coronavirus epidemic is progressing abroad, and there are still occasional epidemics in China, so we can't relax at all times to fight against the epidemic, and the epidemic prevention materials should be fully prepared. As a high-tech enterprise of disease diagnosis, TargetingOne always takes maintaining people's health as its responsibility and keeps introducing suitable solutions for neostriatal virus detection. It has independently developed neostriatal-related products based on three major technology platforms: digital PCR, fluorescent quantitative PCR and immunization, and achieved full process coverage from sample collection to detection. Up to now, all of our products have been qualified for export and registered in foreign countries, contributing to the fight against global epidemics.